Donald M. Stablein

Företagsledare/Principal på

National Cancer Institute

Miscellaneous

Consumer Services

Commercial Services

Profil

Donald M.
Stablein is currently working as a Statistical Editor at the National Cancer Institute.
Prior to this, he worked as an Assistant Professor at the Medical College of Virginia and as the President of The Emmes Co. LLC.
He holds a doctorate degree from the Medical College of Virginia.

Aktiva positioner av Donald M. Stablein

Företag	Position	Start
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research	Företagsledare/Principal	2010-11-04

Alla aktiva positioner av Donald M. Stablein

Tidigare kända positioner av Donald M. Stablein

Företag	Position	Slut
Medical College of Virginia Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	-
The Emmes Co. LLC The Emmes Co. LLC Miscellaneous Commercial ServicesCommercial Services Operates as a full-service clinical research organization which focuses on public health and biopharmaceuticals	President	-

Se detaljerna i Donald M. Stableins erfarenhet

Donald M. Stableins utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Donald M. Stableins erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	3
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research	Miscellaneous
Medical College of Virginia Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Emmes Co. LLC The Emmes Co. LLC Miscellaneous Commercial ServicesCommercial Services Operates as a full-service clinical research organization which focuses on public health and biopharmaceuticals	Commercial Services